Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-027549

Director sold 14,608 shares at $28.00 ($409,024)

  • Director acquired 14,608 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GREY MICHAEL G · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-03 Exercise or conversion : show line 1 in the form 10b5-1 +14,608 $2.94 $42,889 14,608 D
2023-05-03 Sale : show line 2 in the form 10b5-1 −14,608 $28.00 $409,024 0 D
Open-market sales · 14,608 sh · avg $28.00 · $409,024

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-03 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −14,608 360,392 D
Loading xslF345X04/doc4.xml…